Andrew Scott leads Global live Institute’s (GLI) policy department by actively advancing patient-centric strategies through undertaking proactive legislative and regulatory initiatives that positively improve the lives of all impacted by liver disease. Andrew is a consensus builder and appreciates all issue perspectives while presenting parties with creative solutions that value both patient interests and association objectives. Andrew built his strong foundation in health policy, marketing, stakeholder engagement/advocacy, government affairs, and pharmaceuticals as an integral part of Cullari Communications Global, and the Endo Pharmaceuticals Government Affairs team. He has experience as the sole lobbying lead, establishing coalitions, developing advocacy outreach plans, directing advocates and third-party stakeholders, and managing Political Action Committees. Whether it was during his career, or studying public health at Johns Hopkins University, Andrew has established an expansive level of experience and knowledge that he employs to address current public health priorities.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.